BMO Capital Markets restated their outperform rating on shares of Monsanto Co. (NYSE:MON) in a report published on Saturday morning. BMO Capital Markets currently has a $128.00 price objective on the stock.
Other equities analysts have also recently issued reports about the company. Piper Jaffray Cos. reiterated an overweight rating and set a $127.00 price target (up from $95.00) on shares of Monsanto in a report on Monday, June 13th. Zacks Investment Research cut Monsanto from a hold rating to a strong sell rating in a report on Friday. Argus reiterated a buy rating and set a $128.00 price target (up from $111.00) on shares of Monsanto in a report on Wednesday, June 15th. Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $122.43 price target for the company in a report on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the company a sell rating in a report on Monday, June 27th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of Buy and an average target price of $114.67.
Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The firm has a market cap of $45.23 billion, a P/E ratio of 45.49 and a beta of 1.19. The firm has a 50-day moving average price of $104.86 and a 200 day moving average price of $101.43. Monsanto has a one year low of $83.73 and a one year high of $114.26.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. The business earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.19) EPS. On average, analysts forecast that Monsanto will post $4.89 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
In related news, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.
Several hedge funds have recently bought and sold shares of MON. FMR LLC increased its stake in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. Third Point LLC acquired a new stake in Monsanto during the second quarter worth $206,820,000. Carmignac Gestion acquired a new stake in Monsanto during the second quarter worth $197,555,000. TIAA CREF Investment Management LLC increased its stake in Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock worth $481,732,000 after buying an additional 1,560,646 shares during the period. Finally, Adage Capital Partners GP L.L.C. increased its stake in Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock worth $176,327,000 after buying an additional 1,147,200 shares during the period. Hedge funds and other institutional investors own 79.02% of the company’s stock.